Media hype on Denmarks decision to halt AZD1222 vaccination
While media reports suggest AstraZenecas COVID-19 jab might have caused blot clots, the EMA didn’t confirm a causal relationship.
Author Archive for: TG
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1162 entries already.
Entries by Thomas Gabrielczyk
Roche Phase III study misses COVID-19 endpoint
/in News/by Thomas GabrielczykSwiss Roche AG has missed the primary endpoint in the REMDACTA trial in patients with severe COVID-19 pneumonia.
BioPhero A/S raises US$17m in Series A funding
/in News/by Thomas GabrielczykDanish sustainable crop protection company, BioPhero AS, has raised $17m in Series A funding led by DCVC Bio.
PCR-test reveals risk of genotoxity of genome editing
/in News/by Thomas GabrielczykGerman researchers have presented a new method to assess on-target and off-target effects of CRISPR-Cas nucleases or TALENs.
EMA starts rolling review for Sputnik V vaccine
/in News/by Thomas GabrielczykEMAs human medicines committee has started a rolling review of Sputnik V, a COVID-19 vaccine developed by Russias Gamaleya National Centre of Epidemiology and Microbiology.
CAC builds biofuel plant for OMV
/in News/by Thomas GabrielczykChemieanlagenbau Chemnitz (CAC) is realizing one of the first large-scale plants in Europe to use innovative co-processing to produce carbon-neutral fuels.
French biotech investors launch spin-out alliance
/in News/by Thomas GabrielczykKurma Parnters and Francee investment bank have launched a 50m project named Argobio that is aimed at identifiying the most genious biotech ideas and spin out companies.
Oxular Ltd raises US$37m
/in News/by Thomas GabrielczykBritish Oxular Ltd has raised $37m in a financing round led by Forbion Parners and co-financed by IP Group, NeoMed, and V-Bio Ventures to push its pipeline.
EU life science PPPs face less budget in Horizon Europe
/in News/by Thomas GabrielczykThe European Commission is set to fund ten "European Partnerships" partnered with different industries with 10bn.
MosaMeat BV closes US$85m Series B financing
/in News/by Thomas GabrielczykCultured meat producer MosaMeat BV has announced the third and final closing of its Series B round raising US$85m.